Sammanfattning
High selectivity (82 %) to 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene- 1,2-diol, a potent anti-Parkinson drug, was achieved in the isomerization of verbenol oxide at the conversion level of 96 % in N,N-dimethylacetamide at 140 °C over a metal modified zeolite, Fe-Beta-300 with SiO2 to Al2O3 ratio of 300. This catalyst exhibits both weak and medium strong Brønsted and Lewis acid sites.
Originalspråk | Engelska |
---|---|
Sidor (från-till) | 449-458 |
Antal sidor | 10 |
Tidskrift | Reaction Kinetics, Mechanisms and Catalysis |
Volym | 110 |
Nummer | 2 |
DOI | |
Status | Publicerad - aug. 2013 |
MoE-publikationstyp | A1 Tidskriftsartikel-refererad |